Astrazeneca Ab v. Cipla Limited

Court

District Court, D. New Jersey (D.N.J.)
Official Court Website →

Assigned judge

Mary L. Cooper · 4,087 cases in index

Docket number

3:16-cv-09583

Cause

35:271 Patent Infringement
35 U.S.C. § 271 — Patent infringement

Nature of suit

830 Patent
Infringement of a patented invention.

Jurisdiction

Federal Question

Jury demand

None

Date filed

12/29/2016

Date terminated

09/29/2017

3,652 Patent cases in this court are indexed here.

Parties

• plaintiff · AstraZeneca Ab · 185 cases
• defendant · Cipla Limited · 55 cases

About Patent Lawsuits

Patent lawsuits allege infringement of a patented invention — that another party made, used, or sold a protected technology without authorization. These cases are common in technology and pharmaceutical industries.

Frequently Asked Questions

What is Astrazeneca Ab v. Cipla Limited?

Astrazeneca Ab v. Cipla Limited is a federal patent lawsuit filed on 12/29/2016 in the District Court, D. New Jersey. The case was terminated on 09/29/2017. Patent lawsuits allege infringement of a patented invention — that another party made, used, or sold a protected technology without authorization. These cases are common in technology and pharmaceutical industries.

What type of case is this?

It is classified as “Patent” under the federal nature-of-suit system. Patent lawsuits allege infringement of a patented invention — that another party made, used, or sold a protected technology without authorization. These cases are common in technology and pharmaceutical industries.

What court is the case in?

The case is in the District Court, D. New Jersey, docket number 3:16-cv-09583.

When was the case filed?

Astrazeneca Ab v. Cipla Limited was filed on 12/29/2016. It was terminated on 09/29/2017.

What law is the case brought under?

The docket lists the cause as 35 U.S.C. § 271 — Patent infringement.